CN Stock MarketDetailed Quotes

China Resources Double-Crane Pharmaceutical (600062)

Watchlist
  • 17.58
  • -0.14-0.79%
Market Closed May 15 15:00 CST
18.26BMarket Cap11.23P/E (TTM)

China Resources Double-Crane Pharmaceutical (600062) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Slow disease service platform3.25B29.56%
Specialist business platform3.05B27.69%
Infusion service platform2.53B23.03%
原料药业务平台1.26B11.46%
Other788.65M7.17%
Other business119.54M1.09%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Non-infusion product8.35B75.89%
Infusion product2.53B23.03%
Other business119.54M1.09%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Central China and East China5.36B48.69%
North China2.01B18.24%
South and Southwest China1.76B15.96%
Other areas731.18M6.65%
Northwest region642.13M5.84%
Northeast area389.04M3.54%
Other business119.54M1.09%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More